Methylprednisolone Active Not Recruiting Phase 2 Trials for Graft Versus Host Disease (GVHD) / Graft-versus-host Disease (GVHD) Treatment

IndicationsStatusPurposePhase
Active Not RecruitingTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT02953678A Study of Ruxolitinib in Combination With Corticosteroids for the Treatment of Steroid-Refractory Acute Graft-Versus-Host Disease (REACH-1)